Delivery Order SPE2DB22D2009-SPE2DB26FL5ZA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $55,027.37 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 21, 2025. This firm fixed-price contract, awarded on August 20, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of REPATHA 140 mg/mL SureClick auto-injectors with a ceiling value of $48,141.39. This competitively awarded, firm fixed price delivery order is not set-aside and has an ultimate completion date of August 20, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a...
- The Defense Logistics Agency awarded a delivery order valued at $45,892.66 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This non-competitive, firm fixed-price delivery order was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025. The pharmaceutical products will be sourced from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,595.00 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors. This competitive award, issued on November 13, 2025, with a completion date of November 14, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office division as...
- The Defense Logistics Agency awarded a delivery order valued at $1,955.33 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This competitive award, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a firm fixed-price transaction with no set-aside designation. The drug will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $19,204.12 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $15,001.90 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $15,101.87 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a pharmaceutical product used in cardiovascular disease management. This non-set-aside, competitively awarded contract was issued on November 25, 2025, with an ultimate completion date of November 26, 2025, and reflects a firm fixed-price arrangement. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $15,662.94 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/mL SureClick auto-injectors. This competitive, non-set-aside contract utilizes firm fixed price terms and was executed on November 13, 2025, with an ultimate completion date of November 14, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a $21,968.74 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, a cardiovascular medication used to lower cholesterol levels. This firm fixed-price contract, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB26FL5ZADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $35,687.57 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, a pharmaceutical product used in cardiovascular disease management. The contract, awarded on October 27, 2025, with an ultimate completion date of October 28, 2025, operates under a firm fixed-price structure with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies a broad range of medications, vaccines, and medical devices to support military and veteran healthcare systems worldwide. The company's substantial IDC demonstrates its established capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.7k | 10/27/25 |